Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population

To examine whether the coronavirus disease 2019 (COVID-19) pandemic altered risk of adverse pregnancy-related outcomes and whether there were differences by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection status among pregnant women. In this retrospective cohort study using Ep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetrics and gynecology (New York. 1953) 2021-10, Vol.138 (4), p.542-551
Hauptverfasser: Son, Moeun, Gallagher, Kieran, Lo, Justin Y., Lindgren, Eric, Burris, Heather H., Dysart, Kevin, Greenspan, Jay, Culhane, Jennifer F., Handley, Sara C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 551
container_issue 4
container_start_page 542
container_title Obstetrics and gynecology (New York. 1953)
container_volume 138
creator Son, Moeun
Gallagher, Kieran
Lo, Justin Y.
Lindgren, Eric
Burris, Heather H.
Dysart, Kevin
Greenspan, Jay
Culhane, Jennifer F.
Handley, Sara C.
description To examine whether the coronavirus disease 2019 (COVID-19) pandemic altered risk of adverse pregnancy-related outcomes and whether there were differences by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection status among pregnant women. In this retrospective cohort study using Epic's Cosmos research platform, women who delivered during the pandemic (March-December 2020) were compared with those who delivered prepandemic (matched months 2017-2019). Within the pandemic epoch, those who tested positive for SARS-CoV-2 infection were compared with those with negative test results or no SARS-CoV-2 diagnosis. Comparisons were performed using standardized differences, with a value greater than 0.1 indicating meaningful differences between groups. Among 838,489 women (225,225 who delivered during the pandemic), baseline characteristics were similar between epochs. There were no significant differences in adverse pregnancy outcomes between epochs (standardized difference
doi_str_mv 10.1097/AOG.0000000000004547
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8454282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2564953290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4534-f96509c4455ee680471ad65a4ed84a5caf854498154830d94146cce6454f2ee13</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EokvhHyDkYzlk8cc4sS9I1RZKpUq7EhT1Zhln0g0k9tZOWvXfY-hSCr7Mwe88M6OHkNecLTkzzbvj9emSPXqgoHlCFlw3shJSXj4lC8aEqRoNcEBe5Py9hHht5HNyIAGk5JotyOUqphjcTZ_mTE_6jC4jFYwberRafz07qbh5SzcutDj2npZKNwmvggv-jq7nyccRM-0DdfRi-XlJN3E3D27qY3hJnnVuyPhqXw_JxccPX1afqvP16dnq-LzyoCRUnakVMx5AKcRaM2i4a2vlAFsNTnnXaQVgNFegJWsNcKi9x7pc2wlELg_J-3vubv42YusxTMkNdpf60aU7G11v__0J_dZexRurC0JoUQBHe0CK1zPmyY599jgMLmCcsxWqBqOkMKxE4T7qU8w5YfcwhjP7S4otUuz_Ukrbm8crPjT9sfCXexuHCVP-Mcy3mOwW3TBtf_NqoVhlzJ5aFbENyJ-dkZSd</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564953290</pqid></control><display><type>article</type><title>Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Son, Moeun ; Gallagher, Kieran ; Lo, Justin Y. ; Lindgren, Eric ; Burris, Heather H. ; Dysart, Kevin ; Greenspan, Jay ; Culhane, Jennifer F. ; Handley, Sara C.</creator><creatorcontrib>Son, Moeun ; Gallagher, Kieran ; Lo, Justin Y. ; Lindgren, Eric ; Burris, Heather H. ; Dysart, Kevin ; Greenspan, Jay ; Culhane, Jennifer F. ; Handley, Sara C.</creatorcontrib><description>To examine whether the coronavirus disease 2019 (COVID-19) pandemic altered risk of adverse pregnancy-related outcomes and whether there were differences by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection status among pregnant women. In this retrospective cohort study using Epic's Cosmos research platform, women who delivered during the pandemic (March-December 2020) were compared with those who delivered prepandemic (matched months 2017-2019). Within the pandemic epoch, those who tested positive for SARS-CoV-2 infection were compared with those with negative test results or no SARS-CoV-2 diagnosis. Comparisons were performed using standardized differences, with a value greater than 0.1 indicating meaningful differences between groups. Among 838,489 women (225,225 who delivered during the pandemic), baseline characteristics were similar between epochs. There were no significant differences in adverse pregnancy outcomes between epochs (standardized difference&lt;0.10). In the pandemic epoch, 108,067 (48.0%) women had SARS-CoV-2 testing available; of those, 7,432 (6.9%) had positive test results. Compared with women classified as negative for SARS-CoV-2 infection, those who tested positive for SARS-CoV-2 infection were less likely to be non-Hispanic White or Asian or to reside in the Midwest and more likely to be Hispanic, have public insurance, be obese, and reside in the South or in high social vulnerability ZIP codes. There were no significant differences in the frequency of preterm birth (8.5% vs 7.6%, standardized difference=0.032), stillbirth (0.4% vs 0.4%, standardized difference=-0.002), small for gestational age (6.4% vs 6.5%, standardized difference=-0.002), large for gestational age (7.7% vs 7.7%, standardized difference=-0.001), hypertensive disorders of pregnancy (16.3% vs 15.8%, standardized difference=0.014), placental abruption (0.5% vs 0.4%, standardized difference=0.007), cesarean birth (31.2% vs 29.4%, standardized difference=0.039), or postpartum hemorrhage (3.4% vs 3.1%, standardized difference=0.019) between those who tested positive for SARS-CoV-2 infection and those classified as testing negative. In a geographically diverse U.S. cohort, the frequency of adverse pregnancy-related outcomes did not differ between those delivering before compared with during the pandemic, nor between those classified as positive compared with negative for SARS-CoV-2 infection during pregnancy.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1097/AOG.0000000000004547</identifier><identifier>PMID: 34433180</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Contents ; COVID-19 - complications ; COVID-19 - epidemiology ; COVID-19 Testing - statistics &amp; numerical data ; Female ; Humans ; Infant, Newborn ; Original Research ; Pregnancy ; Pregnancy Complications, Infectious - epidemiology ; Pregnancy Complications, Infectious - virology ; Pregnancy Outcome - epidemiology ; Prenatal Care - statistics &amp; numerical data ; Retrospective Studies ; SARS-CoV-2 ; United States - epidemiology</subject><ispartof>Obstetrics and gynecology (New York. 1953), 2021-10, Vol.138 (4), p.542-551</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4534-f96509c4455ee680471ad65a4ed84a5caf854498154830d94146cce6454f2ee13</citedby><cites>FETCH-LOGICAL-c4534-f96509c4455ee680471ad65a4ed84a5caf854498154830d94146cce6454f2ee13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34433180$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Son, Moeun</creatorcontrib><creatorcontrib>Gallagher, Kieran</creatorcontrib><creatorcontrib>Lo, Justin Y.</creatorcontrib><creatorcontrib>Lindgren, Eric</creatorcontrib><creatorcontrib>Burris, Heather H.</creatorcontrib><creatorcontrib>Dysart, Kevin</creatorcontrib><creatorcontrib>Greenspan, Jay</creatorcontrib><creatorcontrib>Culhane, Jennifer F.</creatorcontrib><creatorcontrib>Handley, Sara C.</creatorcontrib><title>Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>To examine whether the coronavirus disease 2019 (COVID-19) pandemic altered risk of adverse pregnancy-related outcomes and whether there were differences by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection status among pregnant women. In this retrospective cohort study using Epic's Cosmos research platform, women who delivered during the pandemic (March-December 2020) were compared with those who delivered prepandemic (matched months 2017-2019). Within the pandemic epoch, those who tested positive for SARS-CoV-2 infection were compared with those with negative test results or no SARS-CoV-2 diagnosis. Comparisons were performed using standardized differences, with a value greater than 0.1 indicating meaningful differences between groups. Among 838,489 women (225,225 who delivered during the pandemic), baseline characteristics were similar between epochs. There were no significant differences in adverse pregnancy outcomes between epochs (standardized difference&lt;0.10). In the pandemic epoch, 108,067 (48.0%) women had SARS-CoV-2 testing available; of those, 7,432 (6.9%) had positive test results. Compared with women classified as negative for SARS-CoV-2 infection, those who tested positive for SARS-CoV-2 infection were less likely to be non-Hispanic White or Asian or to reside in the Midwest and more likely to be Hispanic, have public insurance, be obese, and reside in the South or in high social vulnerability ZIP codes. There were no significant differences in the frequency of preterm birth (8.5% vs 7.6%, standardized difference=0.032), stillbirth (0.4% vs 0.4%, standardized difference=-0.002), small for gestational age (6.4% vs 6.5%, standardized difference=-0.002), large for gestational age (7.7% vs 7.7%, standardized difference=-0.001), hypertensive disorders of pregnancy (16.3% vs 15.8%, standardized difference=0.014), placental abruption (0.5% vs 0.4%, standardized difference=0.007), cesarean birth (31.2% vs 29.4%, standardized difference=0.039), or postpartum hemorrhage (3.4% vs 3.1%, standardized difference=0.019) between those who tested positive for SARS-CoV-2 infection and those classified as testing negative. In a geographically diverse U.S. cohort, the frequency of adverse pregnancy-related outcomes did not differ between those delivering before compared with during the pandemic, nor between those classified as positive compared with negative for SARS-CoV-2 infection during pregnancy.</description><subject>Adult</subject><subject>Contents</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 Testing - statistics &amp; numerical data</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Original Research</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - epidemiology</subject><subject>Pregnancy Complications, Infectious - virology</subject><subject>Pregnancy Outcome - epidemiology</subject><subject>Prenatal Care - statistics &amp; numerical data</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>United States - epidemiology</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhi0EokvhHyDkYzlk8cc4sS9I1RZKpUq7EhT1Zhln0g0k9tZOWvXfY-hSCr7Mwe88M6OHkNecLTkzzbvj9emSPXqgoHlCFlw3shJSXj4lC8aEqRoNcEBe5Py9hHht5HNyIAGk5JotyOUqphjcTZ_mTE_6jC4jFYwberRafz07qbh5SzcutDj2npZKNwmvggv-jq7nyccRM-0DdfRi-XlJN3E3D27qY3hJnnVuyPhqXw_JxccPX1afqvP16dnq-LzyoCRUnakVMx5AKcRaM2i4a2vlAFsNTnnXaQVgNFegJWsNcKi9x7pc2wlELg_J-3vubv42YusxTMkNdpf60aU7G11v__0J_dZexRurC0JoUQBHe0CK1zPmyY599jgMLmCcsxWqBqOkMKxE4T7qU8w5YfcwhjP7S4otUuz_Ukrbm8crPjT9sfCXexuHCVP-Mcy3mOwW3TBtf_NqoVhlzJ5aFbENyJ-dkZSd</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Son, Moeun</creator><creator>Gallagher, Kieran</creator><creator>Lo, Justin Y.</creator><creator>Lindgren, Eric</creator><creator>Burris, Heather H.</creator><creator>Dysart, Kevin</creator><creator>Greenspan, Jay</creator><creator>Culhane, Jennifer F.</creator><creator>Handley, Sara C.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population</title><author>Son, Moeun ; Gallagher, Kieran ; Lo, Justin Y. ; Lindgren, Eric ; Burris, Heather H. ; Dysart, Kevin ; Greenspan, Jay ; Culhane, Jennifer F. ; Handley, Sara C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4534-f96509c4455ee680471ad65a4ed84a5caf854498154830d94146cce6454f2ee13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Contents</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 Testing - statistics &amp; numerical data</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Original Research</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - epidemiology</topic><topic>Pregnancy Complications, Infectious - virology</topic><topic>Pregnancy Outcome - epidemiology</topic><topic>Prenatal Care - statistics &amp; numerical data</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Son, Moeun</creatorcontrib><creatorcontrib>Gallagher, Kieran</creatorcontrib><creatorcontrib>Lo, Justin Y.</creatorcontrib><creatorcontrib>Lindgren, Eric</creatorcontrib><creatorcontrib>Burris, Heather H.</creatorcontrib><creatorcontrib>Dysart, Kevin</creatorcontrib><creatorcontrib>Greenspan, Jay</creatorcontrib><creatorcontrib>Culhane, Jennifer F.</creatorcontrib><creatorcontrib>Handley, Sara C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Son, Moeun</au><au>Gallagher, Kieran</au><au>Lo, Justin Y.</au><au>Lindgren, Eric</au><au>Burris, Heather H.</au><au>Dysart, Kevin</au><au>Greenspan, Jay</au><au>Culhane, Jennifer F.</au><au>Handley, Sara C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>138</volume><issue>4</issue><spage>542</spage><epage>551</epage><pages>542-551</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><abstract>To examine whether the coronavirus disease 2019 (COVID-19) pandemic altered risk of adverse pregnancy-related outcomes and whether there were differences by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection status among pregnant women. In this retrospective cohort study using Epic's Cosmos research platform, women who delivered during the pandemic (March-December 2020) were compared with those who delivered prepandemic (matched months 2017-2019). Within the pandemic epoch, those who tested positive for SARS-CoV-2 infection were compared with those with negative test results or no SARS-CoV-2 diagnosis. Comparisons were performed using standardized differences, with a value greater than 0.1 indicating meaningful differences between groups. Among 838,489 women (225,225 who delivered during the pandemic), baseline characteristics were similar between epochs. There were no significant differences in adverse pregnancy outcomes between epochs (standardized difference&lt;0.10). In the pandemic epoch, 108,067 (48.0%) women had SARS-CoV-2 testing available; of those, 7,432 (6.9%) had positive test results. Compared with women classified as negative for SARS-CoV-2 infection, those who tested positive for SARS-CoV-2 infection were less likely to be non-Hispanic White or Asian or to reside in the Midwest and more likely to be Hispanic, have public insurance, be obese, and reside in the South or in high social vulnerability ZIP codes. There were no significant differences in the frequency of preterm birth (8.5% vs 7.6%, standardized difference=0.032), stillbirth (0.4% vs 0.4%, standardized difference=-0.002), small for gestational age (6.4% vs 6.5%, standardized difference=-0.002), large for gestational age (7.7% vs 7.7%, standardized difference=-0.001), hypertensive disorders of pregnancy (16.3% vs 15.8%, standardized difference=0.014), placental abruption (0.5% vs 0.4%, standardized difference=0.007), cesarean birth (31.2% vs 29.4%, standardized difference=0.039), or postpartum hemorrhage (3.4% vs 3.1%, standardized difference=0.019) between those who tested positive for SARS-CoV-2 infection and those classified as testing negative. In a geographically diverse U.S. cohort, the frequency of adverse pregnancy-related outcomes did not differ between those delivering before compared with during the pandemic, nor between those classified as positive compared with negative for SARS-CoV-2 infection during pregnancy.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>34433180</pmid><doi>10.1097/AOG.0000000000004547</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0029-7844
ispartof Obstetrics and gynecology (New York. 1953), 2021-10, Vol.138 (4), p.542-551
issn 0029-7844
1873-233X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8454282
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Adult
Contents
COVID-19 - complications
COVID-19 - epidemiology
COVID-19 Testing - statistics & numerical data
Female
Humans
Infant, Newborn
Original Research
Pregnancy
Pregnancy Complications, Infectious - epidemiology
Pregnancy Complications, Infectious - virology
Pregnancy Outcome - epidemiology
Prenatal Care - statistics & numerical data
Retrospective Studies
SARS-CoV-2
United States - epidemiology
title Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Outcomes in a U.S. Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A22%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronavirus%20Disease%202019%20(COVID-19)%20Pandemic%20and%20Pregnancy%20Outcomes%20in%20a%20U.S.%20Population&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Son,%20Moeun&rft.date=2021-10-01&rft.volume=138&rft.issue=4&rft.spage=542&rft.epage=551&rft.pages=542-551&rft.issn=0029-7844&rft.eissn=1873-233X&rft_id=info:doi/10.1097/AOG.0000000000004547&rft_dat=%3Cproquest_pubme%3E2564953290%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2564953290&rft_id=info:pmid/34433180&rfr_iscdi=true